Neurogene (NGNE) Shares Outstanding (2013 - 2026)

Neurogene (NGNE) has 14 years of Shares Outstanding (Entity) data on file, last reported at $22.3 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 6.24% year-over-year to $22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.3 million (up 6.24% YoY) and the FY2025 annual result came in at $21.3 million, up 43.57% from the prior year.
• Shares Outstanding (Entity) improved to $22.3 million in Q1 2026, from $21.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $22.3 million in Q1 2026 to a low of $491867.0 in Q4 2023.
• A 5-year average of $11.3 million and a median of $14.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) sank 82.19% — and 2024, when it soared 2920.07%.
• Tracing NGNE's Shares Outstanding (Entity) over 5 years: stood at $2.8 million in 2022, then slumped by 82.19% to $491867.0 in 2023, then soared by 2920.07% to $14.9 million in 2024, then surged by 43.57% to $21.3 million in 2025, then climbed by 4.59% to $22.3 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $22.3 million (Q1 2026), $21.3 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.